Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism APP modulators(Beta amyloid A4 protein modulators), Melatonin receptor agonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | US | - | |
Brain Injuries, Traumatic | Discovery | US | - | |
Cerebral Amyloid Angiopathy | Discovery | US | - | |
Diabetic Retinopathy | Discovery | US | - | |
Dystrophy, Macular | Discovery | US | - | |
Glaucoma | Discovery | US | - |